Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

MEG3-miRNAs help control wool traits in young Tan sheep by regulating immune responses, but their decline with age leads to wool changes.

Trichohyalin may trigger the immune response causing alopecia areata.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

PRP shows promise in treating joint and spine issues, but translating lab results to humans is challenging.

Vitiligo treatment is improving with new drugs and therapies, focusing on personalized and combined approaches.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Smart delivery methods for CRISPR gene editing are crucial for clinical success.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Perilla frutescens, an East Asian plant, contains 400 bioactive compounds that have various health benefits, including anti-inflammatory, antidepressant, and anticancer effects, and can treat conditions like diabetes, skin allergies, and neurological disorders.

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

Enhancing Tregs can protect against alopecia areata.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

CD8 T cells need interferon gamma to cause Alopecia Areata.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

NXC736 significantly reduced hair loss in mice with alopecia areata.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.